Compare Stocks → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:AQSNYSEARCA:DNLNYSEARCA:EPINYSE:EVG Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAQSAequus PharmaceuticalsC$0.02-25.0%C$0.02C$0.01▼C$0.06C$1.99M0.37124,794 shs15,000 shsDNLWisdomTree Global ex U.S. Quality Dividend Growth Fund$37.40+1.0%$38.19$31.77▼$39.30$617.10M0.9474,258 shs28,634 shsEPIWisdomTree India Earnings Fund$44.46+1.0%$43.84$32.15▼$45.02$2.95B0.561.08 million shs601,369 shsEVGEaton Vance Short Duration Diversified Income Fund$10.44+0.5%$10.59$9.13▼$10.86N/AN/A49,033 shs9,949 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAQSAequus Pharmaceuticals0.00%0.00%0.00%-40.00%-50.00%DNLWisdomTree Global ex U.S. Quality Dividend Growth Fund+0.97%-0.90%-3.11%+3.86%+4.12%EPIWisdomTree India Earnings Fund+1.02%+1.34%+4.22%+8.12%+38.76%EVGEaton Vance Short Duration Diversified Income Fund-0.29%+0.77%-1.32%-0.38%+4.82%The "Smart Money" Is Ready for May 1st Are You? (Ad)Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAQSAequus PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ADNLWisdomTree Global ex U.S. Quality Dividend Growth FundN/AN/AN/AN/AN/AN/AN/AN/AEPIWisdomTree India Earnings FundN/AN/AN/AN/AN/AN/AN/AN/AEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAQSAequus PharmaceuticalsN/AN/AN/AN/ADNLWisdomTree Global ex U.S. Quality Dividend Growth Fund0.00N/A$43.9517.51% UpsideEPIWisdomTree India Earnings Fund0.00N/AN/AN/AEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAQSAequus PharmaceuticalsC$1.17M1.70C$0.00 per share5.00C($0.03) per share-0.50DNLWisdomTree Global ex U.S. Quality Dividend Growth FundN/AN/AN/AN/AN/AN/AEPIWisdomTree India Earnings FundN/AN/AN/AN/AN/AN/AEVGEaton Vance Short Duration Diversified Income Fund$13.79MN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAQSAequus Pharmaceuticals-C$3.27M-C$0.02N/A∞N/AN/A-1,569.60%-83.91%6/4/2024 (Estimated)DNLWisdomTree Global ex U.S. Quality Dividend Growth FundN/AN/A22.61∞N/AN/AN/AN/AN/AEPIWisdomTree India Earnings FundN/AN/A15.51∞N/AN/AN/AN/AN/AEVGEaton Vance Short Duration Diversified Income FundN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAQSAequus PharmaceuticalsN/AN/AN/AN/AN/ADNLWisdomTree Global ex U.S. Quality Dividend Growth Fund$1.554.14%N/AN/AN/AEPIWisdomTree India Earnings Fund$1.964.41%N/AN/AN/AEVGEaton Vance Short Duration Diversified Income Fund$0.928.81%+1.91%N/A1 YearsLatest EVG, EPI, CP1, AQS, and DNL DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/1/2024EVGEaton Vance Short Duration Diversified Income FundMonthly$0.07909.01%4/22/20244/23/20244/30/20243/1/2024EVGEaton Vance Short Duration Diversified Income Fundmonthly$0.07868.6%3/20/20243/21/20243/28/20242/1/2024EVGEaton Vance Short Duration Diversified Income Fundmonthly$0.07878.7%2/21/20242/22/20242/29/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAQSAequus Pharmaceuticals138.880.120.46DNLWisdomTree Global ex U.S. Quality Dividend Growth FundN/AN/AN/AEPIWisdomTree India Earnings FundN/AN/AN/AEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAQSAequus PharmaceuticalsN/ADNLWisdomTree Global ex U.S. Quality Dividend Growth FundN/AEPIWisdomTree India Earnings FundN/AEVGEaton Vance Short Duration Diversified Income FundN/AInsider OwnershipCompanyInsider OwnershipAQSAequus Pharmaceuticals14.68%DNLWisdomTree Global ex U.S. Quality Dividend Growth FundN/AEPIWisdomTree India Earnings FundN/AEVGEaton Vance Short Duration Diversified Income FundN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAQSAequus Pharmaceuticals12132.63 millionN/ANot OptionableDNLWisdomTree Global ex U.S. Quality Dividend Growth FundN/A16.50 millionN/ANot OptionableEPIWisdomTree India Earnings FundN/A66.40 millionN/ANot OptionableEVGEaton Vance Short Duration Diversified Income FundN/AN/AN/ANot OptionableEVG, EPI, CP1, AQS, and DNL HeadlinesSourceHeadlineEaton Vance Risk-Managed Diversified Equity Income Fund (ETJ)finance.yahoo.com - March 1 at 3:31 PMEaton Vance Short Stock (NYSE:EVG) Dividends: History, Yield and Datesbenzinga.com - February 23 at 2:00 PMEaton Vance Tax Advantaged Dividend Income Closed Fund (EVT)investing.com - February 22 at 5:24 AMBuy 3 Eaton Vance Mutual Funds Nowmsn.com - December 13 at 7:32 AMEaton Vance Short Duration Diversified Income Fund declares $0.0744 dividendmsn.com - November 3 at 9:30 AMEaton Vance Short Duration Inflation-Protected Income Fundthestreet.com - October 6 at 11:48 PMEVG: Improving Income Generation Is Positive, But Still Not Attractively Pricedmsn.com - September 27 at 7:09 PMEaton Vance Short Duration Diversified Income Fund (NYSE: EVG)fool.com - September 18 at 12:26 AMEaton Vance Limited Duration Income Fund declares $0.0783 dividendmsn.com - September 4 at 3:57 AMEVG - Eaton Vance Short Duration Diversified Income Fundfinance.yahoo.com - August 26 at 8:50 AMEaton Vance Short Duration Government Income Fund;Awsj.com - July 21 at 1:10 PMEaton Vance Short: Dividend Insightsmsn.com - June 16 at 2:55 PMEaton Vance Short Duration Diversified Income Fund (EVG) Declares $0.07 Dividendmsn.com - June 4 at 12:32 PMEaton Vance Short Stock (NYSE:EVG), Guidance and Forecastbenzinga.com - April 21 at 10:21 AMEaton Vance Short Duration Government Income Fund;Iwsj.com - September 21 at 8:54 AMEaton Vance Short Duration Diversified Income Fund declares $0.0924 dividendseekingalpha.com - September 3 at 6:26 PMEaton Vance Short Duration Diversified Income Fund raises dividend 0.9% to $0.0921 shareseekingalpha.com - August 5 at 7:11 PMEaton Vance Short Duration Diversified Income Fund declares $0.0913 dividendseekingalpha.com - July 8 at 1:39 AMDistribution Dates and Amounts Announced for...benzinga.com - July 2 at 7:56 PMEaton Vance Short Duration Diversified Income Fund declares $0.0958 dividendseekingalpha.com - June 4 at 7:34 AMEaton Vance Short Duration Diversified Income Fund goes ex-dividend on Mondayseekingalpha.com - May 20 at 5:28 PMEaton Vance Short Duration Diversified Income Fund declares $0.1013 dividendseekingalpha.com - April 7 at 4:22 PMEaton Vance Short Duration Diversified Income Fund declares $0.1029 dividendseekingalpha.com - March 4 at 7:38 PMEaton Vance Short Duration Diversified Income Fund declares $0.1073 dividendseekingalpha.com - February 7 at 2:07 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAequus PharmaceuticalsCVE:AQSAequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.WisdomTree Global ex U.S. Quality Dividend Growth FundNYSEARCA:DNLWisdomTree World ex-U.S. Growth Fund (the Fund), formerly WisdomTree Japan Equity Income Fund, seeks investment results that correspond to the price and yield performance of the WisdomTree World ex-U.S. Growth Index (the Index). The Index is a fundamentally weighted index that measures the performance of growth companies in the developed and emerging markets outside of the United States. The Index consists of dividend paying companies that pass WisdomTrees market capitalization, liquidity and other requirements. WisdomTree creates a growth score for each company based on the company's earnings per share, sales per share, book value per share and price per share. The top 30% of companies with the highest growth scores within the 1,000 largest companies by market capitalization are included in the Index. Companies are weighted in the Index annually based on annual cash dividends paid. The Fund's investment advisor is WisdomTree Asset Management, Inc.WisdomTree India Earnings FundNYSEARCA:EPIWisdomTree India Earnings Fund (The Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree India Earnings Index. The Index measures the performance of profitable companies incorporated and traded in India that are eligible to be purchased by foreign investors and that meet specific criteria developed by WisdomTree Investments.Eaton Vance Short Duration Diversified Income FundNYSE:EVGEaton Vance Short Duration Diversified Income Fund is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in fixed income markets of the United States. It primarily invests in senior, secured floating-rate loans, bank deposits denominated in foreign currencies, debt obligations of foreign governmental and corporate issuers, and mortgage-backed securities. The fund invests in fixed income securities operating across diversified sectors. It invests in fixed income securities with an average duration of 1.76 years and an average credit quality of least BBB. The fund benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. It was formerly known as Eaton Vance Low Duration Diversified Income Fund. Eaton Vance Short Duration Diversified Income Fund was formed on February 28, 2005 and is domiciled in the United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.